Comparative Pharmacology
Head-to-head clinical analysis: GENERLAC versus GO EVAC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GENERLAC versus GO EVAC.
GENERLAC vs GO-EVAC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lactulose is a synthetic disaccharide that is not absorbed in the small intestine. It is metabolized by colonic bacteria to short-chain fatty acids (e.g., lactic, acetic, and formic acids), which osmotically increase intraluminal water content, soften stool, and stimulate peristalsis. In hepatic encephalopathy, the acidic environment reduces intestinal ammonia production and absorption by promoting conversion of NH3 to NH4+.
Promotes gastrointestinal motility by acting as a stimulant laxative, likely through direct irritation of the colonic mucosa and possibly via local effects on enteric neurons.
10-45 mL orally once daily, adjusted to produce 2-3 soft stools per day. Maximum 60 mL/day.
10 mg orally once daily, with or without food.
None Documented
None Documented
Not applicable; lactulose is a non-absorbable disaccharide that exerts a local osmotic effect in the colon without systemic absorption. Systemic half-life is not relevant as it does not enter circulation.
4.5-6 hours in healthy volunteers; prolonged to 10-14 hours in elderly patients and those with moderate renal impairment (CrCl 30-50 mL/min).
Primarily fecal (≥90%) as unchanged drug via colonic excretion; renal elimination is negligible (<1%).
Primarily renal; approximately 60% eliminated unchanged in urine within 24 hours, with 20% as metabolites. Biliary/fecal excretion accounts for 15-20%, and the remainder is metabolized via glucuronidation.
Category C
Category C
Osmotic Laxative
Osmotic Laxative